NASDAQ
TCMD

Tactile Systems Technology Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Tactile Systems Technology Inc Stock Price

Vitals

Today's Low:
$17.99
Today's High:
$18.32
Open Price:
$18.08
52W Low:
$6.52
52W High:
$26.11
Prev. Close:
$18.16
Volume:
181337

Company Statistics

Market Cap.:
$426.05 million
Book Value:
6.768
Revenue TTM:
$266.35 million
Operating Margin TTM:
3.76%
Gross Profit TTM:
$175.98 million
Profit Margin:
0.13%
Return on Assets TTM:
2.45%
Return on Equity TTM:
0.26%

Company Profile

Tactile Systems Technology Inc had its IPO on 2016-07-28 under the ticker symbol TCMD.

The company operates in the Healthcare sector and Medical Devices industry. Tactile Systems Technology Inc has a staff strength of 982 employees.

Stock update

Shares of Tactile Systems Technology Inc opened at $18.08 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $17.99 - $18.32, and closed at $18.05.

This is a -0.61% slip from the previous day's closing price.

A total volume of 181,337 shares were traded at the close of the day’s session.

In the last one week, shares of Tactile Systems Technology Inc have slipped by -5.5%.

Tactile Systems Technology Inc's Key Ratios

Tactile Systems Technology Inc has a market cap of $426.05 million, indicating a price to book ratio of 2.0279 and a price to sales ratio of 0.957.

In the last 12-months Tactile Systems Technology Inc’s revenue was $266.35 million with a gross profit of $175.98 million and an EBITDA of $16.53 million. The EBITDA ratio measures Tactile Systems Technology Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Tactile Systems Technology Inc’s operating margin was 3.76% while its return on assets stood at 2.45% with a return of equity of 0.26%.

In Q2, Tactile Systems Technology Inc’s quarterly earnings growth was a positive 179.4% while revenue growth was a positive 14.6%.

Tactile Systems Technology Inc’s PE and PEG Ratio

Forward PE
149.2537
Trailing PE
605.3333
PEG
17.236

Its diluted EPS in the last 12-months stands at $0.03 per share while it has a forward price to earnings multiple of 149.2537 and a PEG multiple of 17.236. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Tactile Systems Technology Inc’s profitability.

Tactile Systems Technology Inc stock is trading at a EV to sales ratio of 1.1384 and a EV to EBITDA ratio of -74.9404. Its price to sales ratio in the trailing 12-months stood at 0.957.

Tactile Systems Technology Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$273.73 million
Total Liabilities
$48.52 million
Operating Cash Flow
$-851000.00
Capital Expenditure
$851000
Dividend Payout Ratio
0%

Tactile Systems Technology Inc ended 2024 with $273.73 million in total assets and $0 in total liabilities. Its intangible assets were valued at $273.73 million while shareholder equity stood at $158.76 million.

Tactile Systems Technology Inc ended 2024 with $0 in deferred long-term liabilities, $48.52 million in other current liabilities, 23000.00 in common stock, $-11607000.00 in retained earnings and $31.06 million in goodwill. Its cash balance stood at $63.21 million and cash and short-term investments were $76.43 million. The company’s total short-term debt was $5,497,000 while long-term debt stood at $44.44 million.

Tactile Systems Technology Inc’s total current assets stands at $149.56 million while long-term investments were $0 and short-term investments were $13.22 million. Its net receivables were $48.33 million compared to accounts payable of $9.30 million and inventory worth $20.32 million.

In 2024, Tactile Systems Technology Inc's operating cash flow was $-851000.00 while its capital expenditure stood at $851000.

Comparatively, Tactile Systems Technology Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$18.05
52-Week High
$26.11
52-Week Low
$6.52
Analyst Target Price
$29.67

Tactile Systems Technology Inc stock is currently trading at $18.05 per share. It touched a 52-week high of $26.11 and a 52-week low of $26.11. Analysts tracking the stock have a 12-month average target price of $29.67.

Its 50-day moving average was $20.89 and 200-day moving average was $17.35 The short ratio stood at 1.07 indicating a short percent outstanding of 0%.

Around 106.9% of the company’s stock are held by insiders while 9039.7% are held by institutions.

Frequently Asked Questions About Tactile Systems Technology Inc

The stock symbol (also called stock or share ticker) of Tactile Systems Technology Inc is TCMD

The IPO of Tactile Systems Technology Inc took place on 2016-07-28

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$7.56
-0.1
-1.31%
$6.16
0.81
+15.14%
$1754.25
-24.75
-1.39%
Mowi ASA ADR (MHGVY)
$18.04
-0.15
-0.82%
$2195.3
-111.6
-4.84%
$15.49
0.04
+0.26%
$33.27
-3.69
-9.98%
$2.33
0.07
+3.1%
$2.69
-0.08
-2.89%
$9.23
-0.44
-4.55%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for the treatment of underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, treatment, and share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest for the treatment of retained pulmonary secretions, such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Address

3701 Wayzata Boulevard, Minneapolis, MN, United States, 55416